Home Blog Page 461

Yili’s Cremo Brings Immersive Summer Fun to Thai Youth

BANGKOK, April 28, 2026 /PRNewswire/ — What kind of refreshing surprise can a single ice cream bring to the height of scorching Thai summer? As temperatures soar, finding moments of cool relief has become an essential part of consumers’ daily lives.


Stepping up to meet this seasonal demand, Thai ice cream brand Cremo recently launched its immersive consumer campaign “Cremo Boost It To The Max” (ครีโมบูสต์ฟินอินทุกเลเยอร์), delivering a vibrant and breezy escape for the public amidst the intense summer heat.

In a recent episode of the hit Thai outdoor variety show Running Man Thailand, Cremo featured its brand ambassador Billkin Putthipong in a special appearance. Through custom-designed games like the “Flying Chair Challenge,” the brand seamlessly blended product moments with pure entertainment. The show’s fast-paced, highly interactive format brought out the carefree vitality of summer through laughter and challenges, successfully reinforcing Cremo’s “fun, surprise and youthful” brand identity.

On social media, Cremo consistently rolled out diverse content tailored to the lifestyles of the younger generation. From trendy challenges to lighthearted, feel-good posts and relatable daily scenarios, the content resonates authentically with young Thai consumers. This strategy elevates the brand beyond a mere product, positioning it as a true lifestyle companion. By engaging directly and playfully with its audience, Cremo continues to build stronger connections with younger consumers.

As online buzz builds, Cremo has seamlessly extended its campaign offline. At brand ambassador Billkin’s recent concert in Bangkok, Cremo created an interactive zone that combined music, vibrant energy, and a refreshing product experience, offering fans a highly engaging, multi-dimensional brand encounter.

The on-site activation featured ice cream tasting, interactive photo booths, and limited-edition merchandise giveaways, creating an engaging, immersive experience for attendees. Concertgoers were able to enjoy refreshing treats while soaking up the live atmosphere. In this relaxed and joyful setting, Cremo fostered authentic interactions with consumers, bringing the idea of “summer refreshment” to life through a tangible, memorable experience.


As a Thai ice cream brand under Yili Group—Asia’s leading dairy company—Cremo remains deeply committed to local consumer needs, continuously driving product innovation and enhancing the brand experience. Backed by Yili’s global quality control systems and robust R&D capabilities, Cremo has consistently elevated both its product quality and consumer engagement. As a result, Cremo saw steady growth in both market share and brand awareness in 2025, earning widespread recognition across the Thai market.

From hit variety shows to social media platforms and from online campaigns to offline activations, Cremo has brought its core philosophy of being “innovative, fun, and full of surprises” to life across consumer touchpoints. This summer, Cremo is not only delivering a refreshing taste but also bringing an extra layer of joy and relaxation to the everyday lives of Thai consumers.

DuRoBo Rolls Out Software Update 1.2 for Krono

NEW YORK, April 28, 2026 /PRNewswire/ — DuRoBo, creator of the ePaper focus hub, has recently launched Software Update 1.2 for Krono, continuing its steady cadence of meaningful improvements designed to make the device more intuitive. Building on earlier updates, this latest version underscores DuRoBo’s commitment to actively refining the Krono experience post-launch.

Durobo
Durobo

Version 1.2 introduces a native browser app, giving users direct access to the web within Krono. Desktop customization now lets users pin their favorite apps directly to the home screen. Korean language support also arrives as a full system language and within Spark transcription, alongside Chinese and Japanese—making Krono more accessible for a global audience. In addition, the Smart Dial, Krono’s tactile control for navigation, access to Spark, screen refresh, and brightness, brings smooth page-turning and scrolling to third-party reading apps such as Kindle, Kobo Books, and Play Books. These enhancements make Krono more versatile while preserving its core minimalist design—keeping users in rhythm without constant touch interactions.

This release expands the foundation laid by Version 1.1, which introduced the Transfer app for fast, wireless file sharing, making it easier to move content onto the device. Version 1.1 also brought flexible reading controls, including customizable fonts, layouts, and margins, along with saved Spark summaries for easy access and refinement. A more polished bookshelf and a cleaner user interface for greater calm on Krono.

DuRoBo has maintained this responsive approach with the quick follow-up Version 1.2.1, which adds an Invert Scrolling option for the Smart Dial based on user feedback, reinforcing its approach of delivering incremental improvements rather than waiting for major overhauls. DuRoBo remains committed to evolving Krono through thoughtful, user-driven updates that enhance its role as the definitive ePaper focus hub.

About DuRoBo
DuRoBo is a Dutch tech company specializing in ePaper products, including eReaders, tablets, and monitors. With a robust supply chain, exceptional hardware and software development capabilities, and original design expertise, DuRoBo operates across consumer products, industry solutions, and customized collaborations. More information can be found at https://www.durobo.com/ 

Bybit Pay Expands to South Africa With MoneyBadger, Enabling Nationwide Crypto QR Payments

DUBAI, UAE, April 28, 2026 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, has expanded its payment solution, Bybit Pay, to South Africa through an integration with  MoneyBadger, a South African crypto payments integration provider that enables QR-based transactions and settlement in rand through partnerships with major payment networks, enabling users to make everyday purchases using cryptocurrency across a wide network of merchants.

The integration marks a further step in the adoption of cryptocurrency for daily transactions in one of Africa’s most active digital asset markets. South Africa has an estimated 9.44% cryptocurrency ownership rate, representing approximately 5.8 million people, with around 52% of holders already using crypto for purchases, according to Triple-A’s 2024 estimates.

The integration allows Bybit Pay users in South Africa to complete transactions by scanning QR codes or paying online at supported merchants. The rollout supports a range of everyday spending categories, including groceries, fuel, travel, retail and dining. Users can pay with Bitcoin, stablecoins and more than 20 supported digital assets.

Through its partnership with MoneyBadger, Bybit Pay integrates with several established South African payment networks. Users can access more than 650,000 locations via Scan to Pay, 31,000 locations through Zapper, and over 1,500 Pick n Pay stores. Additional coverage is available both in-store and online via Peach (across 120 merchants) and Ozow (across 440+ merchants).

The integration leverages existing QR and pay link infrastructure, allowing retailers to receive settlement in South African rand through their current payment systems without needing to hold cryptocurrency or add new payment integrations. MoneyBadger converts crypto to rand at the point of sale, reducing exposure to price volatility.

Bybit Pay supports both in-store and online transactions. For in-store payments, users open the Bybit app, navigate to Bybit Pay, scan a merchant QR code and confirm the transaction. For online purchases, users select cryptocurrency as a payment method at checkout, proceed via the Bybit app and confirm payment details.

To access the service, users must activate Bybit Pay within the app and complete identity verification requirements. The platform supports QR-based payments and online checkout without transaction fees for QR Pay. Payment limits range from $0.06 to $2,500 per transaction, with most payments processed within 10 to 15 seconds.

Bybit serves more than 80 million users globally and supports South African rand deposits, positioning the platform to expand its footprint in the region.

South Africa ranks among the leading cryptocurrency markets globally, according to the World Crypto Rankings 2025 report, which evaluates 79 countries using more than 28 metrics and 90 data points across user adoption, transactional activity, regulatory infrastructure and cultural engagement. The report highlights that the strongest-performing markets are those where crypto is actively used for payments and everyday financial activity, reflecting a broader shift toward real-world utility.

“Crypto payments are entering a new phase where the focus is shifting from trading to real-world utility,” said Sophie Chen, Head of Marketing at Bybit Card and Bybit Pay. “Bybit Pay connects digital assets to everyday commerce, and our partnership with MoneyBadger enables seamless spending across South Africa.”

“At MoneyBadger, our goal is to make paying with Bitcoin and crypto as simple as scanning a QR code,” said Carel van Wyk, CEO of MoneyBadger. “By enabling Bybit Pay across our network, millions of users can now spend crypto at everyday merchants across South Africa, while merchants continue to receive settlement in rand.”

The partnership is expected to support broader adoption of cryptocurrency payments, with initiatives aimed at encouraging first-time and repeat usage across participating merchants.

#Bybit / #TheCryptoHub / #NewFinancialPlatform / #MoneyBadger

Bybit Fintech FZE is a juristic representative of Altify SA Capital (Pty) Ltd, an authorised financial services provider (FSP No. 52727), registered under South African company number 2022/321703/07

Bybit Pay Expands to South Africa With MoneyBadger, Enabling Nationwide Crypto QR Payments
Bybit Pay Expands to South Africa With MoneyBadger, Enabling Nationwide Crypto QR Payments

About Bybit

Bybit is the world’s second-largest cryptocurrency exchange by trading volume, serving a global community of over 80 million users. Founded in 2018, Bybit is redefining openness in the decentralized world by creating a simpler, open and equal ecosystem for everyone. With a strong focus on Web3, Bybit partners strategically with leading blockchain protocols to provide robust infrastructure and drive on-chain innovation. Renowned for its secure custody, diverse marketplaces, intuitive user experience, and advanced blockchain tools, Bybit bridges the gap between TradFi and DeFi, empowering builders, creators, and enthusiasts to unlock the full potential of Web3. Discover the future of decentralized finance at Bybit.com.

For more details about Bybit, please visit Bybit Press

For media inquiries, please contact: media@bybit.com

For updates, please follow: Bybit’s Communities and Social Media

Discord | Facebook | Instagram | LinkedIn | Reddit | Telegram | TikTok | X | Youtube

About MoneyBadger

MoneyBadger is a leading South African Bitcoin payments company enabling safe, seamless crypto transactions online and in physical stores. Merchants settle instantly in Rands, Stablecoins or Bitcoin via its API which supports the Lightning Network and all major wallets including Luno, Binance and VALR. Founded in Stellenbosch in 2022, MoneyBadger bridges legacy POS systems to Bitcoin through QR code scanning. Its first major client, Pick n Pay, launched crypto payments across 1,500+ stores in 2023.

Trusted by top retailers, MoneyBadger raised $400k/R7m in pre-seed funding in 2025 and partnered with Ozow, Peach Payments, Scan to Pay, Ecentric, and Zapper for broader adoption across South Africa at over 650,000 merchant locations.

For more information, visit www.moneybadger.co.za

C-Ray Therapeutics Receives FDA Acceptance of Type II Drug Master File for Copper-64 (Cu-64)

DMF No. 43568 is now active and available for reference in global IND and NDA submissions

CHENGDU, China, April 28, 2026 /PRNewswire/ — C-Ray Therapeutics (Chengdu) Co., Ltd., today announced that its Type II Drug Master File (DMF) for COPPER [64Cu] CHLORIDE FOR RADIOLABELLING has been listed as active by the U.S. Food and Drug Administration (FDA) under DMF No. 43568. The DMF is now available for reference by radiopharmaceutical developers worldwide in support of IND and NDA submissions.

Cu-64: The Next-Generation Diagnostic Radionuclide

Cu-64 offers a half-life of approximately 12.7 hours — significantly longer than the current standard diagnostic radionuclides Ga-68 (T₁/₂ = 68 min) and F-18 (T₁/₂ = 110 min). This extended half-life enables centralized large-scale production, shelf lives of up to 48 hours, and substantially reduced scheduling pressure at imaging centers, improving patient access to PET diagnostics.

Clinical validation of Cu-64 is well established. A 2026 study published in European Urology (IF 25.2) by Clarity Pharmaceuticals, evaluating Cu-64 SAR-bisPSMA (Co-PSMA) in patients with prostate cancer, demonstrated that Cu-64-labeled imaging agents detected more than twice as many lesions as Ga-68 PSMA-11: mean lesions detected per patient were 1.26 vs. 0.48, with a positive detection rate of 78% vs. 36% (p < 0.0001). These advantages position Cu-64 as a leading candidate for next-generation diagnostic radiopharmaceuticals, with particular relevance in oncology indications including neuroendocrine tumors (NETs) and prostate cancer.

Proprietary Manufacturing Platform: Scale and Cost Efficiency

C-Ray Therapeutics has overcome key technical barriers in Cu-64 production through its proprietary manufacturing process and purpose-built, fully automated production facility. The company’s in-house Ni-64 recycling process achieves a recovery rate of up to 90%, allowing recovered high-enrichment Ni-64 to be reused directly in subsequent production cycles. This enables stable, continuous multi-batch operation and substantially reduces raw material costs. Current batch capacity exceeds 2 Ci (end of bombardment, EOB).

C-Ray also offers integrated, end-to-end services encompassing radiolabeling and conjugation, formulation and fill-finish, and cold-chain distribution — a true one-stop solution for radiopharmaceutical developers.

“FDA acceptance of our Cu-64 Type II DMF marks a significant milestone that positions C-Ray Therapeutics as a regulatorily prepared and operationally validated supply partner for diagnostic radiopharmaceuticals,” said Qiao Haitao, General Manager of C-Ray Therapeutics (Chengdu). “This achievement reflects our high standards in manufacturing, quality systems, and regulatory execution, and enables us to support partners from early-stage development through clinical and commercial phases.”— Haitao Qiao, General Manager, C-Ray Therapeutics

Strategic Significance

The FDA acceptance of the Cu-64 DMF validates the robustness of C-Ray’s proprietary manufacturing process, quality systems, and regulatory controls. For domestic biopharmaceutical companies developing Cu-64-based diagnostic agents, this DMF significantly lowers the CMC burden and reduces compliance risk in FDA IND and NDA submissions.

For multinational pharmaceutical companies and global radiopharmaceutical developers, it establishes a reliable, compliant, high-quality Cu-64 supply source from China to support clinical development and registration strategies worldwide. Looking ahead, C-Ray Therapeutics will continue to strengthen its full-chain service capabilities and collaborate with partners across the globe to advance theranostics and expand patient access to precision nuclear medicine.

About C-Ray Therapeutics

C-Ray Therapeutics is a global CRDMO providing end-to-end radiopharmaceutical development services — from target validation and preclinical evaluation to IND-enabling studies, clinical supply, and commercial-scale cGMP manufacturing. Operating from its 28,000-square-meter Chengdu facility under China’s Class A Radiation Safety License, C-Ray supports 30+ radioisotopes and has delivered 100+ projects spanning diagnostic and therapeutic programs, including 5 programs at IND or IND-enabling stage, 7 in clinical supply, and 2 in Phase III clinical trials. For more information, visit www.c-raytherapeutics.com

Notabene launches Revert to solve crypto’s biggest gap: what happens after a transaction settles

New infrastructure lets institutions safely control, authorize, and track returns of settled crypto transactions, a capability that has never existed in blockchain payments, even when regulation requires it.

NEW YORK, April 28, 2026 /PRNewswire/ — Once a crypto transaction settles, there has never been a safe, standardized way to reverse or correct it, even when regulation requires it. Notabene, the trust layer for global money movement, today announced Revert, the first post-settlement control layer for digital asset transactions, enabling institutions to safely coordinate, authorize, and complete returns-of-funds flows across counterparties.

For the first time, institutions can control what happens after a crypto transaction settles, not just before it.

Until now, post-settlement workflows in crypto have been manual, fragmented, and high-risk. The moment a transaction moved between two institutions, there was no coordinated mechanism to return the funds.

While traditional payment systems rely on standardized processes for refunds, corrections and dispute resolution, crypto transactions between institutions have lacked any coordinated mechanism – leaving institutions to rely on email, informal coordination, and unverified wallet addresses.

At the same time, new regulations now require institutions to return funds in certain cases, creating a gap between regulatory obligation and available infrastructure.

Revert closes that gap. Revert introduces a post-settlement control layer for digital assets – enabling institutions to initiate, authorize, and complete return-of-funds flows with verified wallet destinations and a full audit trail.

Built on the Transaction Authorization Protocol (TAP), Revert enables institutions to coordinate refunds across counterparties as a shared network standard, rather than within closed ecosystems.

“Blockchain finality makes sense for settlement. It doesn’t make sense for everything else institutional payments actually require: coordinating across counterparties, correcting mistakes, and unwinding transactions that shouldn’t have gone through,” said Pelle Braendgaard, CEO of Notabene. “Revert is the first post-settlement control layer that works between institutions rather than inside them, and crypto can’t credibly support real business payments without it.”

Revert is available today across the Notabene Network, which already connects more than 2,200 regulated institutions across 100+ jurisdictions and has processed over $2 trillion in compliant transaction volume. The launch lands as return-of-funds obligations are tightening across jurisdictions. Under the EU Transfer of Funds Regulation, for example, a Crypto-Asset Service Provider that detects missing Travel Rule information after a transaction has settled must return the funds to the originator, a workflow that has been operationally difficult until now.

For more on Revert, visit notabene.id/revert

About Notabene

Notabene is the trust layer for global money movement. The Notabene network connects thousands of trusted counterparties, facilitating trillions of dollars in transaction volume annually across over 100 jurisdictions. Notabene provides industry-leading tools for stablecoin payment coordination, real-time transaction authorization, counterparty verification, and self-hosted wallet identification—helping institutions build trust into every transaction.

 

Supermicro Expands Data Center Building Block Solutions® Flexibility with Arm-Based Platforms and OCP Systems for Next-Gen AI Infrastructure

  • Arm AGI CPU-based platforms increase performance-per-watt for modern workloads
  • High-density liquid-cooled systems accelerate HPC and AI workloads
  • Flexible infrastructure supports agentic AI across cloud and enterprise environments

SAN JOSE, Calif., April 28, 2026 /PRNewswire/ — Super Micro Computer, Inc. (NASDAQ: SMCI), an AI, Enterprise, Storage, 5G/Edge Total Solution provider, today expanded its Data Center Building Block Solutions (DCBBS) portfolio with new Arm®-based server platforms powered by the new Arm AGI CPU, and new Open Compute Project (OCP) ORv3-compliant rack offerings. Supermicro leads the industry with over 20 OCP Inspired™ systems, which incorporate various OCP technologies and form factors, to simplify open data center deployments.

Super_Micro_Data_Center_Solutions
Super_Micro_Data_Center_Solutions

“Supermicro continues to advance its DCBBS with an expanded portfolio of Arm-based platforms and OCP systems for next-gen AI and HPC,” said Charles Liang, president and CEO of Supermicro. “With high-density, liquid-cooled systems and energy-efficient Arm architectures, we enable scalable, flexible data centers that maximize performance-per-watt and accelerate AI adoption across cloud and enterprise environments.”

DCBBS delivers complete, modular AI infrastructure. Built from validated components and sub-systems, DCBBS provides end-to-end deployment flexibility – from individual GPUs and networking switches to complete racks, site infrastructure, management software, and professional services.

“The rapid growth of AI is reshaping infrastructure requirements across the data center,” said Mohamed Awad, Executive Vice President, Cloud AI Business Unit, Arm. “Arm AGI CPU-based platforms, built on Arm Neoverse technology, provide the foundation for this new generation of compute, and our collaboration with Supermicro brings these capabilities to market in flexible, high-density systems optimized for modern AI and cloud environments.”

“By integrating energy-efficient Arm Neoverse platforms into Supermicro’s ORv3 portfolio, the OCP Community is extending the open supply chain for AI infrastructure. This collaboration delivers the modular, liquid-cooled building blocks required to scale high-performance, energy-efficient data centers across the entire ecosystem,” said Steve Helvie, Chief Emerging Ecosystem Officer, OCP Foundation.

Supermicro’s expanded OCP ORv3 portfolio includes new rack configurations and purpose-built servers designed for seamless integration and high-performance workloads. A new 2U GPU system, compatible with 21-inch OCP ORv3 racks, features dual Intel® Xeon® 6 6700 series processors with P-cores, a 1400A busbar inspired by OCP with power shelves, and DC-SCM support. The system integrates the NVIDIA HGX™ B300 8-GPU platform with 5th Generation NVLink®, delivering the compute density and bandwidth required for large-scale AI deployments. Learn more here.   

Also available for ORv3 environments is Supermicro’s FlexTwin™ system, which is a high-density, dual-node platform that integrates two independent servers in a 1-OU chassis. Designed for HPC and AI workloads, the system supports the latest Intel processors and future Intel and AMD CPUs. The FlexTwin leverages Supermicro’s DLC-2 liquid cooling solution for CPUs, memory, and VRMs—removing up to 90%* of system generated heat. Learn more here.

In addition, Supermicro is making available two new Arm-based systems powered by the recently announced Arm AGI CPU in 2U and 5U form factors, delivering high core density, expanded memory capacity, and flexible I/O for energy-efficient, scalable agentic AI infrastructure.

Systems Overview:

  • Compact 2U Server
    • Arm AGI CPU with 64, 128, or 136 Arm Neoverse® V3 cores
    • 24 DIMM slots, for up to 6TB of DDR5 memory
    • 8 front hot-swap 2.5″ NVMe drive bays
    • Details here
  • Expanded 5U server  
    • Arm AGI CPU with 64, 128, or 136 Arm Neoverse V3 cores
    • 24 DIMM slots, for up to 6TB of DDR5 memory
    • 8 front hot-swap 2.5″ NVMe drive bays
    • Additional PCIe lanes for increasing the number of GPUs, in an I/O rich configuration  
    • Details here

Supermicro promotes staff volunteering at the Open Compute Project Foundation, where the company holds a seat on the OCP Advisory Board. Learn more about how Supermicro supports OCP activities and initiatives here.

*Based on Supermicro estimates

About Super Micro Computer, Inc.

Supermicro (NASDAQ: SMCI) is a global leader in Application-Optimized Total IT Solutions. Founded and operating in San Jose, California, Supermicro is committed to delivering first-to-market innovation for Enterprise, Cloud, AI, and 5G Telco/Edge IT Infrastructure. We are a Total IT Solutions provider with server, AI, storage, IoT, switch systems, software, and support services. Supermicro’s motherboard, power, and chassis design expertise further enables our development and production, enabling next-generation innovation from cloud to edge for our global customers. Our products are designed and manufactured in-house (in the US, Asia, and the Netherlands), leveraging global operations for scale and efficiency and optimized to improve TCO and reduce environmental impact (Green Computing). The award-winning portfolio of Server Building Block Solutions® allows customers to optimize for their exact workload and application by selecting from a broad family of systems built from our flexible and reusable building blocks that support a comprehensive set of form factors, processors, memory, GPUs, storage, networking, power, and cooling solutions (air-conditioned, free air cooling or liquid cooling).

Supermicro, Server Building Block Solutions, and We Keep IT Green are trademarks and/or registered trademarks of Super Micro Computer, Inc.

All other brands, names, and trademarks are the property of their respective owners.

 

Nuevocor Appoints Dr. Monica Shah as Chief Medical Officer

SINGAPORE, PARIS and PHILADELPHIA, April 28, 2026 /PRNewswire/ — Nuevocor, a clinical-stage biotechnology company developing novel therapies for patients suffering from life-threatening cardiomyopathies, today announced the appointment of Monica Shah, MD, FACC, as Chief Medical Officer. Dr. Shah will lead the Company’s global clinical development and medical affairs at an inflection point as Nuevocor prepares to initiate a first-in-human clinical study of NVC-001 in patients with LMNA-associated dilated cardiomyopathy (DCM), one of the most aggressive forms of genetic heart disease.

A board-certified heart failure and transplant cardiologist, Dr. Shah brings more than two decades of experience in cardiovascular medicine and drug development across academia, NIH, and industry, including leadership roles in both biotech and CRO organizations. Most recently, she served as Chief Medical Officer of CTI Clinical Trial & Consulting, a specialty CRO, where she oversaw medical strategy across a broad portfolio of complex clinical programs spanning rare disease, gene therapy, and cardiovascular indications. Prior to CTI, she was Senior Vice President and AAV Global Program Head at Rocket Pharmaceuticals, where she launched and led pivotal clinical programs in cardiovascular gene therapy. She previously served as Vice President and Global Head of Cell and Gene Therapy at IQVIA, leading the company’s multidisciplinary CGT Center of Excellence and partnering with sponsors to advance programs from early clinical development through commercialization. Earlier in her career, Dr. Shah spent nearly a decade at the National Institutes of Health, serving as Deputy Chief of Heart Failure and Arrhythmias at the National Heart, Lung, and Blood Institute and Director of the Trial Innovation Network at the National Center for Advancing Translational Sciences.

“Monica is an exceptional clinical development leader who brings precisely the right combination of cardiovascular expertise, gene therapy execution and regulatory experience to Nuevocor. As we prepare to initiate the first-in-human clinical trial of NVC-001 in LMNA DCM and continue advancing our mechanobiology platform toward multiple genetically defined cardiomyopathy indications, we look forward to her leadership in bringing novel therapeutics to patients with serious unmet medical need,” said Al Gianchetti, Chief Executive Officer of Nuevocor.

“LMNA DCM is a devastating disease with very limited options for patients, and Nuevocor’s mechanobiology-driven approach represents a genuinely differentiated opportunity to intervene at the level of disease biology,” said Dr. Shah. “I am proud to join this team at such an important moment and look forward to advancing NVC-001 into the clinic and translating the broader promise of our differentiated platform into clinical programs for patients in need.”

About NVC-001

NVC-001 is a first-in-class, gene therapy for the treatment of LMNA-related dilated cardiomyopathy (LMNA DCM), one of the most aggressive forms of DCM with a rapid progression toward end-stage heart failure and malignant ventricular arrhythmias associated with increased risk of sudden cardiac death. NVC-001 is designed to reduce forces to the nucleus to restore nuclear envelope integrity, a hallmark of LMNA DCM, and treat disease. In preclinical studies, treatment with NVC-001 demonstrated significant benefits, including survival and cardiac function. Nuevocor plans to initiate a first-in-human clinical trial in 2026.

About Nuevocor

Nuevocor is a biotechnology company developing novel therapies for genetic cardiomyopathies driven by aberrant mechanobiology, headquartered in Singapore with offices in the U.S. and Europe. In 2025, Nuevocor closed a US$50 million financing from Kurma Partners, Angelini Ventures, EDBI (an arm of SG Growth Capital, investment platform of EDB and Enterprise Singapore), ClavystBio, Boehringer Ingelheim Venture Fund, Coronet Ventures and Highlight Capital. Our unique approach, enabled by our proprietary PrOSIA mechanobiology platform, surpasses the limitations of traditional gene replacement therapy – which treats individual gene mutations – to treating defects in shared disease pathways across multiple cardiomyopathies by addressing the functional root cause of disease. Nuevocor is first-in-disease by addressing genetic cardiomyopathies that are not amenable to gene replacement therapy and have no effective treatment options. (www.nuevocor.com)

Media Contact:
Mike Beyer, Sam Brown Healthcare Communications
mikebeyer@sambrown.com
+1 312-961-2502

LEAD TECH to Debut Its Cloud-Integrated CIJ and Laser Coding Suite at Interpack 2026, Backed by 20+ Patents

LEAD TECH, a Certified Continuous Inkjet Printer and Laser Marking Machine Manufacturer Serving 3,000+ Global Clients, Exhibits Full CIJ, Laser, and Piezo Inkjet Coding Solutions at Interpack 2026, Booth 8BC86, Düsseldorf, May 7–13

ZHUHAI, China, April 28, 2026 /PRNewswire/ — LEAD TECH (Zhuhai) Electronic Co., Ltd. will present its full cloud-integrated coding and marking suite at Interpack 2026, Booth 8BC86, Düsseldorf, Germany, running May 7 through 13, bringing industrial date coding and batch marking solutions to one of the world’s most demanding testing grounds for packaging technology.

LEAD TECH Invites the World to Interpack 2026: Discover How Next-Generation CIJ, Laser, and IoT Coding Solutions Are Transforming Global Manufacturing
LEAD TECH Invites the World to Interpack 2026: Discover How Next-Generation CIJ, Laser, and IoT Coding Solutions Are Transforming Global Manufacturing

Fifteen Years from Lab to Global Production Floor
Fifteen years ago, LEAD TECH was a team of engineers in a small facility outside Guangzhou with one problem to solve: continuous inkjet printers kept failing manufacturers at the worst possible moments. That focus on reliability is still what the company is built around. More than 70,000 of its coding machines now run on production floors from Southeast Asia to Western Europe, and roughly a third of its 140-person team works in R&D full time. The technical foundation behind those machines includes a U.S. patent on its CIJ technology, ISO 9001:2015 certification, and more than 20 utility patents. Among the close to 3,000 manufacturers the company serves are Nestlé, Huawei, Dole, and Kweichow Moutai Group, spanning food and beverage, pharmaceutical, automotive, electronics, and cable production.

What Visitors Will See at Booth 8BC86
Attendees at Interpack can expect live demonstrations across the full product range:

  • i9 Series CIJ printers in standard, micro-character, and ultra-high-speed configurations, printing expiration dates, batch codes, barcodes, and QR codes on PET plastic, glass, metal, flexible film, cable, and more
  • CO2, Fiber, and UV laser marking machines, each matched to specific materials and production environments
  • P Series piezo inkjet printers, built for high-contrast coding on paper, cardboard, and other absorbent surfaces
  • A cloud-connected platform across the full range, covering remote monitoring, over-the-air firmware updates, and maintenance alerts for real-time production visibility

Packaging engineers, line managers, and procurement teams from food, pharmaceutical, and industrial manufacturing will find each system running at production speed, with LEAD TECH’s application specialists on hand to work through real substrate and speed requirements.

Proven in the Field: 86 Coding Machines, Five Years, Zero Failures
In 2020, a major Philippine condiment manufacturer was facing a recurring compliance problem: its coding equipment accumulated roughly 60 seconds of time-synchronization error per month, putting export date codes at risk of failing EU regulatory standards. Daily manual recalibration kept things running, but the margin for human error was never fully removed.

LEAD TECH’s engineering team built the RTC wireless synchronization system in response. It connects automatically to a time server over Wi-Fi and switches to a local backup mode if the network drops, removing the need for manual intervention. 86 coding machines were deployed across the client’s production lines. Five years later, not one has reported a failure.

“When a customer in the Philippines runs 86 of your machines for five years without a single issue, that tells you more than any spec sheet,” said Mr. Cauf, General Manager of LEAD TECH. “We come to Interpack because the manufacturers we respect most are the ones who want to test the equipment themselves before they make a decision. That is exactly the conversation we are there for.”

Interpack 2026 and a Look Ahead to Chicago
LEAD TECH’s team will be at Booth 8BC86 throughout all seven days of Interpack, May 7 to 13, available for live product demonstrations, application discussions, and distributor partnership meetings. Later in the year, the company will also exhibit at Pack Expo International 2026, October 18 to 21 in Chicago, Illinois, continuing its effort to bring its coding solutions directly to manufacturers across North America.

About LEAD TECH (Zhuhai) Electronic Co., Ltd.
Founded in 2011 and based in Zhuhai, China, LEAD TECH is an ISO 9001:2015 certified manufacturer of continuous inkjet printers (CIJ), laser marking machines, and piezo inkjet printers for industrial coding and marking. With 20+ patents including a U.S. patent, 80+ distributors globally, and 70,000+ printers installed across food and beverage, pharmaceutical, automotive, electronics, and cable industries, LEAD TECH is committed to making industrial coding simpler, friendlier, and smarter. Visit www.leadtech.ltd to learn more.

Media Contact
LEAD TECH (Zhuhai) Electronic Co., Ltd.
Email: lt@leadtech.ltd
Website: www.leadtech.ltd